MedPath

Lourxime

Brand Name: Lourxime

Generic Name: Cefuroxime (as Sodium)

Active
Registration Number

DRP-11801-03

Dosage Form

Powder for Injection (I.M./I.V.)

Issuance Date

August 1, 2023

Expiry Date

April 29, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength750 mg
PackagingGlass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10mL Type I colorless ampoule (water for injection as diluent) in a box

Classification

C
Classification
Prescription Drug (Rx)
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cefuroxime (as Sodium)Active
Monograph: cefuroxime (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform